Research Article

Association of BTLA Polymorphisms with Susceptibility to Non-Small-Cell Lung Cancer in the Chinese Population

Table 6

Stratified analyses between BTLA rs2171513 G>A polymorphism and NSCLC risk by sex, age, smoking status, alcohol consumption, and BMI.

VariableBTLA rs2171513 G>A (case/control)aAdjusted ORb (95% CI); P
GGGAAAGGGA vs. GGAA vs. GGGA/AA vs. GGAA vs. (GG/GA)

Sex
 Male335/361165/16515/241.001.15 (0.86-1.53); : 0.3460.70 (0.34-1.43); : 0.3251.09 (0.83-1.44); : 0.5450.67 (0.33-1.36); : 0.266
 Female319/221132/11124/131.000.84 (0.61-1.15); : 0.2731.32 (0.65-2.69); : 0.4410.89 (0.66-1.20); : 0.4451.40 (0.69-2.83); : 0.350
Age
 <59305/265133/11421/141.001.02 (0.73-1.40); : 0.9301.58 (0.73-3.42); : 0.2441.06 (0.78-1.46); : 0.6721.58 (0.73-3.39); : 0.244
 ≥59349/317164/16218/231.000.98 (0.74-1.30); : 0.9060.67 (0.35-1.30); : 0.2400.94 (0.72-1.23); : 0.6590.68 (0.35-1.30); : 0.242
Smoking status
 Never408/456188/22729/281.000.97 (0.76-1.24); : 0.8031.18 (0.67-2.08); : 0.5710.99 (0.78-1.26); : 0.9481.19 (0.68-2.09); : 0.543
 Ever246/126109/4910/91.001.08 (0.72-1.63); : 0.6980.58 (0.23-1.48); : 0.2541.01 (0.68-1.48); : 0.9800.57 (0.22-1.44); : 0.232
Alcohol consumption
 Never520/520226/24534/341.000.98 (0.78-1.23); : 0.8290.99 (0.59-1.66); : 0.9670.98 (0.79-1.22); : 0.8341.00 (0.60-1.66); : 0.990
 Ever134/6271/315/31.001.13 (0.65-1.95); : 0.6700.79 (0.17-3.69); : 0.7671.10 (0.64-1.87); : 0.7350.76 (0.17-3.50); : 0.725
BMI (kg/m2)
 <24441/326194/14726/201.001.05 (0.80-1.38); : 0.7110.91 (0.49-1.69); : 0.7611.03 (0.80-1.34); : 0.8030.89 (0.48-1.66); : 0.724
 ≥24213/256103/12913/171.000.93 (0.66-1.30); : 0.6561.09 (0.49-2.40); : 0.8390.94 (0.68-1.30); : 0.7231.11 (0.51-2.44); : 0.791

Notes: athe genotyping was successful in 1,003 (98.70%) NSCLC cases, and 901 (99.33%) controls for BTLA rs2171513 G>A. bAdjusted for age, sex, smoking status, alcohol consumption, and BMI (besides stratified factors accordingly) in a logistic regression model. Abbreviations: BMI: body mass index; NSCLC: non-small-cell lung cancer.